Allergy Therapeutics
AGY.L
#6589
Rank
NZ$1.31 B
Marketcap
NZ$0.21
Share price
-5.06%
Change (1 day)
24.31%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2025: -NZ$91.95 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are NZ$75.57 Million. In 2025 the company made an earning of -NZ$91.95 Million a decrease over its 2024 earnings that were of -NZ$84.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025-NZ$91.95 Million8.65%
2024-NZ$84.63 Million-6.69%
2023-NZ$90.7 Million244.94%
2022-NZ$26.3 Million-404.35%
2021NZ$8.63 M-49.42%
2020NZ$17.08 M83.48%
2019NZ$9.3 M-159.83%
2018-NZ$15.56 Million255.48%
2017-NZ$4.38 Million-84.06%
2016-NZ$27.47 Million-1667.33%
2015NZ$1.75 M-44.68%
2014NZ$3.16 M130.59%
2013NZ$1.37 M-19.89%
2012NZ$1.71 M-127.05%
2011-NZ$6.35 Million2009.96%
2010-NZ$0.31 Million-99.07%
2009-NZ$32.2 Million-53.23%
2008-NZ$68.84 Million-21.86%
2007-NZ$88.1 Million356.94%
2006-NZ$19.28 Million230.75%
2005-NZ$5.83 Million-217.9%
2004NZ$4.94 M-58.79%
2003NZ$11.99 M-196.03%
2002-NZ$12.5 Million